Primary care and public health
- Respiratory
- STI/STI + (DR)
- HPV
- GI
Future Assay Development
The primary focus is to improve health by delivering rapid and accurate results at the point of need.
Research & Development is at the heart of our dedication to provide high quality diagnostic tools to aid clinical decision making. We are continually expanding our product portfolio in key areas of healthare, including primary care, emergency and urgent care, infection prevention and control and global health.
Next Steps for QMDx
- Respiratory Panel
- SARS (SARS-CoV-2)
Launched
- Tuberculosis (TB) (Latent and Drug Resistant)
- HPV (Strategic Partners)
Launching Soon
- Additional Multiplex functionality and extended assay portfolio.
In Development
- Sexually Transmitted Infection (STI) + Drug Resistance (DR)
- Adult (in-patient) Respiratory Panel
- Paediatric (in-patient) Respiratory Panel
- Sepsis
In Development
- Urinary Tract Infection (UTI)
- Hepatitis
- Gastrointestinal (GI)
- Healthcare Associated Infections (HCAI)
- Meningitis/Encephalitis
Future Development
Passionate about point-of-need multiplex diagnostics for:
Emergency and urgent care
- Respiratory
- UTI
- Meningitis and encephalitis
- HCAI
- GI
- Sepsis
Global health
- TB
- STI/STI + (DR)
- HPV
- GI
Infection prevention and control
- HCAI
- GI